CB2 cannabinoid receptor as potential target against Alzheimer’s disease
The CB2 receptor is one of the components of the endogenous cannabinoid system, a complex network of signaling molecules and receptors involved in the homeostatic control of several physiological functions. Accumulated evidence suggests a role for CB2 receptors in Alzheimer's disease (AD) and i...
Main Authors: | Ester eAso, Isidro eFerrer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00243/full |
Similar Items
-
Cannabinoids for treatment of Alzheimer’s disease: moving towards the clinic
by: Isidro eFerrer
Published: (2014-03-01) -
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
by: M. Galán-Ganga, et al.
Published: (2021-05-01) -
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
by: Alicia López, et al.
Published: (2018-05-01) -
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01) -
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
by: Laura Ibanez, et al.
Published: (2021-08-01)